Position in JNJ
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$12,095,321
+$583,909 QoQ
Shares Held
47,625
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
5.31%
of 13F equity value
Holder Rank
#998
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Avengers, Inc. holds $17,063,900 across 8 Drug Manufacturers - General names. JNJ ranks #1 (70.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
47,625 | $12,095,321 | |
| 2 | PFE |
Pfizer Inc
|
131,989 | $3,178,294 | |
| 3 | LLY |
ELI LILLY & Co
|
1,313 | $1,574,851 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,344 | $169,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
132 | $16,962 | |
| 6 | ABBV |
AbbVie Inc.
|
50 | $12,582 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
141 | $8,124 | |
| 8 | AMGN |
Amgen Inc
|
22 | $7,966 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,095,321 | 47,625 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $11,511,412 | 47,093 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $10,232,849 | 49,446 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $9,115,432 | 49,161 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,537,448 | 49,345 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,038,430 | 48,471 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,453,378 | 44,623 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $7,045,072 | 43,472 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $6,167,367 | 42,196 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,594,624 | 41,688 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,249,694 | 39,873 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,161,470 | 39,560 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $6,726,567 | 40,639 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $6,236,890 | 40,238 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,044,448 | 39,878 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,517,247 | 39,895 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $7,002,236 | 39,447 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $6,953,087 | 39,232 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,698,416 | 39,156 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $6,285,095 | 38,917 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $6,296,692 | 38,222 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,093,276 | 37,075 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,235,088 | 33,264 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||